You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《異動股》四環醫藥(00460.HK)續飆40%價量屢創新高
阿思達克 01-21 13:50
四環醫藥(00460.HK)連續第二天呈異動,該股承昨天飆升43%破頂兼獲大成交配合強勢,今天進一步飆至1.86元,創逾廿個月高,現造1.84元,續飆40%,成交續增至4.12億股,為近幾年罕見,涉資7.14億元。

四環醫藥本月中旬公布,控股子公司北京四環製藥開發的左乙拉西坦注射用濃溶液於2020年12月21日獲得國家藥品管理局批准上市。該產品主要用於成人及4歲以上兒童癲癇患者部分性發作(伴或不伴繼發性全面性發作)加用治療。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account